Latest news with #NPPA
Al-Ahram Weekly
12 hours ago
- Business
- Al-Ahram Weekly
Dabaa Nuclear Plant's 1st unit to start operations in H2 2028: Egypt PM - Energy
Prime Minister Mostafa Madbouly confirmed on Wednesday that the first unit of the Dabaa Nuclear Power Plant will begin operations in the second half of 2028. PM Madbouly made this statement while discussing the project's timeline during his visit to the site. He added that the remaining three units are slated for completion in 2029. According to a cabinet statement, Madbouly stated that over 80 percent of the project's workforce is Egyptian, with tens of thousands working on-site. "It is a great honour that Egyptian personnel are trusted to carry out this ambitious undertaking," he expressed. He explained that the plant consists of four nuclear reactors with a total capacity of 4,800 megawatts (MW), each with a capacity of 1,200 MW, and construction is currently underway across all phases of the project. The premier clarified that the Dabaa project is part of Egypt's commitment to having 42 percent of its electricity generation sourced from renewable and clean energy by 2030. According to a separate cabinet statement on Wednesday, the project will be operated entirely by qualified Egyptian personnel from the very first day of operation. Egypt has recently witnessed a sharp increase in electricity loads, culminating in a record high of 37,600 MW last Thursday — the highest so far this year. In previous summers, the country had faced frequent power shortages, leading to rolling blackouts. In 2023, the government introduced a load-shedding programme to alleviate the strain on Egypt's gas network caused by rising temperatures and increased air conditioning use. National dream The prime minister said the project fulfils a national dream the Egyptian people have had since the mid-20th century. 'It is now a tangible reality that reflects our national will and firm determination to possess advanced, safe, and sustainable sources of electricity generation,' he stated. Madbouly added that the project had remained a mere plan on paper for many years, until President Abdel-Fattah El-Sisi's strong political will and determination made it a reality. In 2015, Egypt's Nuclear Power Plants Authority (NPPA) and Russia's State Atomic Energy Corporation (ROSATOM) launched the Dabaa nuclear project in the northwestern governorate of Matrouh. The project is Egypt's first nuclear power facility in the Mediterranean coastal city of Dabaa, approximately 300 kilometres northwest of Cairo. In April 2025, ROSATOM Director General Alexey Likhachev stated that Egypt's Dabaa NPP will become the world's largest nuclear construction project in terms of geographical scale once it is completed by 2030. Follow us on: Facebook Instagram Whatsapp Short link:
Time of India
15-07-2025
- Health
- Time of India
Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates
The Centre has revised the prices of 71 important drug formulations, including those used to treat metastatic breast cancer, diabetes, peptic ulcers, and severe infections. The National Pharmaceutical Pricing Authority ( NPPA ) announced the new prices through a notification. As per the notification, manufacturers may add Goods and Services Tax (GST) only if they have paid or are liable to pay it on the retail price. Medicines for cancer, ulcers, and infections included Among the key drugs listed is Trastuzumab, produced by Reliance Life Sciences, used in the treatment of metastatic breast cancer and gastric cancer. Its price has been fixed at ₹11,966 per vial. Another drug, a combination of clarithromycin, esomeprazole, and amoxicillin used to treat peptic ulcer disease and manufactured by Torrent Pharmaceuticals , will now cost ₹162.5 per tablet. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Trekking pants for mountain sports and adventure travel Trek Kit India Shop Now Undo A combipack containing ceftriaxone, disodium edetate, and sulbactam powder for treating life-threatening infections has been priced at ₹626 per vial. A similar combination drug from Tyykem, in powder form for infusion, will now cost ₹515.5 per vial. Antidiabetic formulations also covered The NPPA notification also includes revised prices for 25 anti-diabetes formulations that contain sitagliptin. It also mentions several antidiabetic combinations containing empagliflozin. Live Events NPPA is the authority that monitors and sets the maximum retail prices of medicines in India to ensure accessibility and affordability. Retailers must display the revised price list In February, the NPPA had issued an order asking drug manufacturers to share the updated price lists with dealers, state drug controllers, and the government. This was aimed at ensuring transparency in drug pricing. "The order to display the price list is to allow citizens to cross-check whether the pharmacies are selling at the price fixed by NPPA or not," said an official. The NPPA's order also stated, "Every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carried on business in a manner so as to be easily accessible to any person wishing to consult the same." The directive also applies to online retail platforms. (Inputs from TOI)
Time of India
15-07-2025
- Health
- Time of India
Centre fixes prices of 71 key drug formulations, including cancer medicines
Representative image NEW DELHI: The Centre has fixed the price of 71 key drug formulations, including medicines approved for treating metastatic breast cancer, allergies and diabetes, among others. Also, the notification issued by the National Pharmaceutical Pricing Authority (NPPA) states that the manufacturer may add Goods and Services Tax (GST) only if they have paid or it is payable to the government on the retail price. The drugs for which prices have been fixed include Trastuzumab by Reliance Life Sciences. It is used in the treatment of metastatic breast cancer and gastric cancer. The NPPA has fixed its price at Rs 11,966 per vial. The price of a combination drug containing clarithromycin, esomeprazole and amoxicillin which is used to treat peptic ulcer disease - a sore on the lining of the stomach - manufactured by Torrent Pharmaceuticals has been fixed at Rs 162.5 per tablet. The price of a combipack of ceftriaxone, disodium edetate and sulbactam powder used to treat life-threatening infections has been fixed at Rs 626 per vial. Another key drug combination used for treating infections containing ceftriaxone, disodium edetate and sulbactam powder for solution for Infusion from Tyykem has been priced at Rs 515.5 per vial, according to the NPPA notification. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Đây có thể là thời điểm tốt nhất để giao dịch vàng trong 5 năm qua IC Markets Tìm hiểu thêm Undo The NPPA has also notified the retail price of 25 anti-diabetes formulations containing sitagliptin as a component, apart from several other antidiabetic formulations containing empagliflozin as a combination in its latest notification. NPPA, a government regulatory agency, is responsible for controlling and revising the prices of pharmaceutical products in India. In February, the regulatory body issued an order stating that drug manufacturers must issue a price list to the dealers, state drug controllers and the government, indicating reference to such price fixation or revision as covered by the order or gazette notification issued by the government from time to time. "The order to display the price list is to allow citizens to cross-check whether the pharmacies are selling at the price fixed by NPPA or not," said an official. "Every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carried on business in a manner so as to be easily accessible to any person wishing to consult the same," the NPPA's February order stated. It added that the directive also covers the virtual/online premises where the retailer or dealer carries on business.
Daily News Egypt
08-07-2025
- Business
- Daily News Egypt
Egypt's Al-Sisi meets Rosatom chief as new Dabaa plant deals are signed
Egyptian President Abdel Fattah Al-Sisi met with the head of Russia's state atomic energy corporation Rosatom on Tuesday in the city of New Alamein to discuss developments on the Dabaa Nuclear Power Plant project, the presidency said. The meeting with Rosatom Director General Alexey Likhachev came as the two countries signed supplementary agreements aimed at accelerating the construction of the plant. Also present at the meeting were the president of Rosatom's engineering division Atomstroyexport, Andrey Petrov, the Russian Ambassador to Cairo, Georgy Borisenko, as well as Egypt's Minister of Electricity and the head of its Nuclear Power Plants Authority (NPPA). Separately on Tuesday, Egyptian and Russian officials held a signing ceremony for the new agreements at the electricity ministry's headquarters in Alamein. Minister of Electricity and Renewable Energy, Mahmoud Essmat, and Rosatom's Likhachev signed a supplementary protocol to the intergovernmental deal on the plant's construction and its physical protection systems. The two officials then witnessed the signing of a related supplementary contract covering the plant's design, procurement, and construction, which was signed by the head of the NPPA, Sherif Helmy Mahmoud, and Atomstroyexport's Andrey Petrov. A statement from the electricity ministry said the agreements were signed as part of both sides' keenness to speed up the project's implementation according to the set timetables. It added that the project is part of Egypt's strategy to rely on clean energy and achieve its updated national energy strategy goals for 2040. 'The cooperation and partnership between Egypt and Russia embody the strong political will of the two friendly countries,' Essmat said in the statement. 'Today's signing… represents an important step towards completing the Dabaa nuclear plant project in its various stages and reflects the fruitful cooperation between Egypt and Russia.' Likhachev affirmed Russia's firm commitment to supporting Egypt's efforts in building its first nuclear power plant. 'We are proud of our strategic partnership with Egypt and look forward to continuing joint cooperation to implement this ambitious project, which will contribute to enhancing energy security in Egypt and achieving sustainable development goals,' he said.
Middle East
08-07-2025
- Business
- Middle East
OPEN// Sisi holds meeting with CEO of Russia's ROSATOM
EL ALAMEIN, Egypt, July 8 (MENA) - President Abdel Fattah El Sisi had a meeting Tuesday with CEO of Russia's State Atomic Energy Corporation Rosatom (ROSATOM) Alexey Likhachev. Electricity and Renewable Energy Minister Mahmoud Esmat, head of the Nuclear Power Plants Authority (NPPA) Sherif Helmy Mahmoud, along with Andrey Petrov, head of Atomstroyexport (ASE) - a subsidiary of the Russian Rosatom and Russian ambassador to Egypt Georgy Borisenko took part in the meeting that was held in El Alamein City. Presidential Spokesman Mohamed el-Shenawy said, the meeting is a part of the Rosatom CEO's visit to Egypt to sign, with the minister of electricity, the supplementary intergovernmental agreement between Egypt and Russia regarding the construction of El-Dabaa Nuclear Power Plant, as well as related protection systems. Both the SEA and the NPPA aim to ink a supplementary contract related to construction details, design, procurement, and execution. Shenawy added that the meeting addressed progress on El-Dabaa Nuclear Power Plant Project for peaceful civilian use, along with all related technical and procedural details. (MENA) K F E/S A S
